3.0.0 2802 2023-01-13T04:47:59Z 2023-01-13T04:47:59Z House H HR 2005-06-08 109 hsif00 Energy and Commerce Committee House Standing hsif17 Innovation, Data, and Commerce Subcommittee Referred to 2005-06-17T15:43:44Z Referred to 2005-06-08T14:00:35Z National Drug Testing Integrity Act 109 4910 HR 2006-03-17 Referred to the Subcommittee on Commerce, Trade and Consumer Protection. Related bill CRS 2005-06-17 hsif17 Innovation, Data, and Commerce Subcommittee 1 House committee actions Referred to the Subcommittee on Commerce, Trade and Consumer Protection. Committee 2005-06-08 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2005-06-08 Introduced in House IntroReferral Intro-H 9 Library of Congress 2005-06-08 Introduced in House IntroReferral 1000 9 Library of Congress E000179 Rep. Engel, Eliot L. [D-NY-17] ELIOT ENGEL D NY L. 17 N D000096 Rep. Davis, Danny K. [D-IL-7] DANNY DAVIS D IL K. 7 2005-06-21 False C000380 Del. Christensen, Donna M. [D-VI-At Large] DONNA CHRISTENSEN D VI M. 0 2005-06-21 False T000459 Rep. Terry, Lee [R-NE-2] LEE TERRY R NE 2 2005-06-28 False E000215 Rep. Eshoo, Anna G. [D-CA-14] ANNA ESHOO D CA G. 14 2005-09-28 False Crime and Law Enforcement Commerce Drug abuse Drug testing Fraud Restrictive trade practices Crime and Law Enforcement 00 2005-06-08 Introduced in House 2005-07-07T21:32:37Z Drug Testing Integrity Act of 2005 - Declares it is unlawful to: (1) knowingly manufacture, market, sell, ship, or otherwise provide to another individual any product with the intent to assist the use of such product to defraud a drug test (that is, to submit a substance that purports to be from an individual other than its actual source, or purports to have been excreted or collected other than when it was actually excreted or collected); or (2) engage in any other conduct with the intent to produce a false or misleading outcome of a test for the presence of a controlled substance.

Grants the Federal Trade Commission enforcement powers as a violation of an unfair or deceptive act or practice.

]]> Drug Testing Integrity Act of 2005 Display Title Drug Testing Integrity Act of 2005 Official Title as Introduced To prohibit the manufacture, marketing, sale, or shipment in interstate commerce of products designed to assist in defrauding a drug test. Introduced in House IH Short Titles as Introduced Drug Testing Integrity Act of 2005 Introduced in House 2005-06-08T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-109hr2802ih/xml/BILLS-109hr2802ih.xml 2005-06-17 Referred to the Subcommittee on Commerce, Trade and Consumer Protection. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.